FAQs Botox®2019-06-10T14:19:48-04:00

FAQs Botox®

What are Botox®, Dysport®, Jeuveau® and Xeomin®

Botox®, Dysport®, Jeuveau® and Xeomin® are all neuromodulators that improve lines and wrinkles of the forehead, brow (frown lines) and crow’s feet areas. This medication relaxes the muscles that cause these lines, smoothing deep furrows that can make you look angry and tired. In many patients the eyebrows are
raised by the procedure, often called the “nonsurgical brow lift.” In select patients, they may be used in the upper lip to relax vertical lines, along the jawline, to improve the corners of the mouth, and in the neck to relax vertical neck bands. Results are more variable in these areas. The Botox® brand of neuromodulator has been used in medicine for almost 2 decades on millions of patients with an excellent safety profile. The newer brands Dysport® and Xeomin® have gone through years of testing and use outside the U.S. before being approved by the FDA and have similar results and potential side effects as Botox®.

When will I see results?*

It takes 2 to 4 days for the frowning, squinting and forehead muscles to start to relax after the initial injection. At 14 days the results are complete. Although fine lines often disappear quickly, deeper furrows may take longer to fade away. In older patients or very deep wrinkles, lines will be improved but not completely eradicated.

How long will the results last?*

Benefits initially last about 3 to 4 months initially. With continued treatments, the duration of muscle relaxation generally becomes longer. Some patients can eventually wait 6 months or longer between treatments. How frequently you are treated is entirely up to you. If the duration of action of the treatment is shorter than expected, or decreases with subsequent treatments, changing brands (for example from Botox® to Dysport®) may be helpful.

Are there risks to the procedure?

Transient bruising at injection sites can occur, particularly if you have had aspirin or ibuprofen (Advil, Motrin) within 1 week, or alcohol within 48 hours of treatment. Occasional brief tenderness or headache may result for a few hours, and rarely longer. Mild, temporary eyelid or eyebrow drooping can last 2-3 weeks or rarely months and may occur in about 1 percent of patients and is never permanent. Extremely rare side effects include temporary double vision, reduced blinking resulting in corneal injury, allergy, and development of antibodies which may decrease the duration of results for future neuromodulator treatments.

Who should not be treated with Neuromodulators (Botox®, Dysport®, Xeomin®, Jeuveau®)?

You may not be treated with neuromodulators if:

  • You are pregnant or nursing.
  • You are allergic to benzyl alcohol or botulinum toxin.
  • You have a neuromuscular disease (such as myasthenia gravis).
  • You are taking aminoglycoside medications (Streptomycin, Neomycin, Gentamycin)

Take the First Step – Request A Consultation

Please fill out the form on this page to request a consultation and one of our knowledgeable medical staff members at Krauss Dermatology will reach out to you promptly. You can also call our Wellesley, MA office directly to schedule – (781) 416-3500.

Krauss Dermatology serves the greater Boston area.

*Individual Results May Vary*

CallEmail GalleryDirections
  • By submitting the contact form, you agree to the Terms of Use:
    Communications through our website or via email are not encrypted and are not necessarily secure. Use of the internet or email is for your convenience only, and by using them, you assume the risk of unauthorized use.
    By submitting your email address and/or telephone number you are providing Krauss Dermatology authorization to contact you about appointments, information and special offers in the practice.
    By submitting a form you hereby agree to hold Krauss Dermatology, its doctors and affiliates, harmless from any hacking or any other unauthorized use of your personal information by outside parties.
  • This field is for validation purposes and should be left unchanged.